Routine Dementia Screening Shows No Benefit or Harm for Family Members

The clinical management of Alzheimer disease and related dementias is increasingly focused on early identification within the disease continuum [1]. Current diagnostic frameworks for mild cognitive impairment (a state where cognitive deterioration is present but activities of daily living remain largely preserved) emphasize the importance of informant reports and objective testing [2]. While comprehensive geriatric assessments often incorporate screening to identify syndromes like sarcopenia (the age-related loss of skeletal muscle mass and strength) or cognitive decline, the utility of routine screening in asymptomatic populations remains a subject of debate among guideline committees [1, 3]. Clinicians must frequently balance the potential for early non-pharmacological interventions with the practical realities of long-term implementation in the home setting [4]. A recent large-scale randomized trial now examines how these screening practices specifically impact the health and readiness of the patients' family members.